Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1995 Aug;21(8):641-4.
doi: 10.1007/BF01711541.

Isoniazid overdose: four case reports and review of the literature

Affiliations
Review

Isoniazid overdose: four case reports and review of the literature

F G Alvarez et al. Intensive Care Med. 1995 Aug.

Abstract

Objectives: To review the pathophysiology, presentation and treatment of isoniazid (INH) intoxication.

Data sources: Human, animal and modeling studies published since 1940 identified through MEDLINE and a review of the bibliographies of relevant articles.

Study selection and data extraction: The studies identified were reviewed with emphasis on the most recent. Earlier studies were selected for their historical value and relevance to the clinical setting.

Data synthesis: Isoniazid overdose is a potentially fatal intoxication. The incidence of tuberculosis has recently increased in the United States and therefore the frequency of INH overdose may also increase. Patients with INH overdose may present with nausea, vomiting, ataxia, symptoms reminiscent of atropine intoxication, coma and grand mal seizures. Lactic acidosis is revealed by laboratory evaluation. Treatment requires admission to the ICU for ventilatory support, and management of seizures and acid-base abnormalities. Pyridoxine, in a dose equivalent to the amount of INH ingested, is the only effective antidote.

Conclusions: INH overdose should be suspected in any patient presenting with seizures and metabolic acidosis. Prognosis is good when treatment is instituted early.

PubMed Disclaimer

References

    1. Am J Hosp Pharm. 1975 Feb;32(2):202-6 - PubMed
    1. South Med J. 1976 Jan;69(1):31-2 - PubMed
    1. Arch Intern Med. 1990 Aug;150(8):1751-3 - PubMed
    1. Am Rev Respir Dis. 1965 Apr;91:600-4 - PubMed
    1. Hum Toxicol. 1987 Nov;6(6):497-501 - PubMed

LinkOut - more resources